Pulmonary rehabilitation is an important aspect of the treatment of patients with chronic obstructive pulmonary disease with a view to improving breathing, exercise capacity, muscle strength, overall physical and mental well-being and health related quality of life.
• although short, three week programmes can have a positive effect on patients with acute exacerbation of chronic obstructive pulmonary disease, longer programmes provide greater benefits and early intervention leads to faster recovery of quality of life • water based exercise programmes are more effective than land based exercise programmes in increasing peak and endurance exercise capacity and improving aspects of quality of life
• the supplemental use of home-based nocturnal non-invasive intermittent positive pressure ventilation (NIPPV) may improve health related quality of life, mood, dyspnoea, gas exchange, exercise tolerance and lung function decline. In 2013, The British Thoracic Society published an evidence-based guideline on pulmonary rehabilitation in adults, summary recommendations from which are reproduced below...
The role of pulmonary rehabilitation
• Pulmonary rehabilitation should be offered to patients with chronic obstructive pulmonary disease (COPD) with a view to improving exercise capacity by a clinically important amount. (Grade A) • Pulmonary rehabilitation should be offered to patients with COPD with a view to improving dyspnoea and health status by a clinically important amount. (Grade A)
• Different components within a pulmonary rehabilitation programme, such as resistance training, can influence quadriceps strength and this is addressed in the section 'Nature of training of these guidelines'. (v) • Pulmonary rehabilitation should be offered to patients with COPD with a view to improving psychological wellbeing. (Grade A)
• As a minimum, efficacy of pulmonary rehabilitation programmes needs to be regularly assessed by demonstrating clinically important improvements in exercise capacity, dyspnoea and health status. • Pulmonary rehabilitation provides opportunities to offer smoking cessation advice. (v) Chronic respiratory failure
• Patients with COPD can be referred for pulmonary rehabilitation regardless of whether or not they have chronic respiratory failure. (Grade D)
• When considering the referral of patients with chronic respiratory failure, practitioners should reflect on the receiving setting and skill mix of the attending staff to provide safe pulmonary rehabilitation to these patients who have significant physiological impairment and potential for greater instability by the intended programme. (v)
Cardiovascular disease comorbidity
• People with chronic respiratory disease should be referred to pulmonary rehabilitation irrespective of coexistent stable cardiovascular disease.
(Grade D) • A coexistent abdominal aortic aneurysm (AAA) <5.5 cm should not preclude referral to pulmonary rehabilitation and being included in moderate intensity aerobic exercise training, provided blood pressure is controlled. (Grade D) • The referral process and/or the initial assessment for pulmonary rehabilitation offer an important opportunity to assess and optimise cardiovascular health and address risk factors for cardiovascular disease. (v) • In patients with COPD who have an AAA >5.5 cm, deemed not fit for surgery, pulmonary rehabilitation incorporating mild-moderate intensity aerobic exercise may be considered, but should not include resistance training. (v)
May 2014
Anxiety and depression
• Coexistent symptoms of anxiety and/or depression in patients with COPD should not preclude referral to pulmonary rehabilitation. (Grade D)
• The referral process and the assessments for pulmonary rehabilitation offer important opportunities to detect and consider referral for ongoing support and management for depression. Other considerations regarding referral to pulmonary rehabilitation • Patients with unstable cardiac disease or locomotor difficulties that preclude exercise (eg, severe arthritis or severe peripheral vascular disease)
should not be referred for pulmonary rehabilitation. (v) • Careful consideration should be given to patients who have significant cognitive or psychiatric impairment that would lead to an inability to follow simple commands in a group setting. (v) • In certain individual cases, facilitation of pulmonary rehabilitation may be aided by the support and attendance of a relative or carer. (v)
• In case of doubt over the appropriateness of a patient for pulmonary rehabilitation, clinicians are advised to contact their local provider. (v)
Structure of pulmonary rehabilitation
• Frequency of supervised pulmonary rehabilitation sessions . Pulmonary rehabilitation programmes should be a minimum of twice-weekly supervised sessions. (Grade D) • In line with published pulmonary rehabilitation studies and the outcomes they demonstrate, a third session of prescribed exercise is recommended.
This can be performed unsupervised. (v) • Encouragement of regular physical activity five times a week for 30 min each time is encouraged in line with standard healthy living advice. (v)
Duration of pulmonary rehabilitation programmes
• Pulmonary rehabilitation programmes of 6-12 weeks are recommended. (Grade A)
• Pulmonary rehabilitation programmes including the attendance at a minimum of 12 supervised sessions are recommended, although individual patients can gain some benefit from fewer sessions. (Grade A) • If training for less than 6 weeks is considered, this should be individualised and objective/subjective measures of benefit in place before patients graduate. For some individuals, reassessment at 4 weeks and graduation to independent gym training is a feasible possibility. 
Interval and continuous aerobic training
• Interval and continuous training can be applied safely and effectively within the context of pulmonary rehabilitation to patients with COPD. (Grade A) • The choice of interval or continuous training will be down to the patient and/or therapist preference. (v)
• In clinical practice, interval training may require a higher therapist to patient ratio to ensure adequate work rate and rest intervals are achieved compared with continuous training. (v)
Goal setting in pulmonary rehabilitation
• Generic exercise training as opposed to individually targeted exercise training is recommended for pulmonary rehabilitation. (Grade D)
• While generic exercise training is recommended as opposed to an individually targeted exercise programme, the prescription of exercise is individualised to provide correct intensity. (v) • Besides the exercise elements of pulmonary rehabilitation, healthcare professionals commonly use goal setting to address specific hurdles. Given the personalised nature of this intervention to a patient's needs, evidence is difficult to quantify. (v) • The term 'goal setting' may require discussion with the patient. (v)
Supervision in pulmonary rehabilitation
• A supervised pulmonary rehabilitation programme is recommended for patients with COPD. (Grade A) • If considering a structured home-based rehabilitation programme for patients with COPD, the following important factors need careful consideration: mechanisms to offer remote support and/or supervision, provision of home exercise equipment and patient selection. (Grade B) • There would be some benefit to increasing the options for pulmonary rehabilitation available to individuals with • COPD, and increase the scope of the service. Geography may limit or stimulate options. (v)
Post-exacerbation pulmonary rehabilitation Outcomes in post-exacerbation pulmonary rehabilitation
• Patients hospitalised for acute exacerbation of COPD should be offered pulmonary rehabilitation at hospital discharge to commence within 1 month of discharge. • The optimal approaches for addressing malnutrition, sarcopenia or obesity in COPD are uncertain and this is a wider issue than this guideline covers. However, attendance at a pulmonary rehabilitation course presents an ideal opportunity to screen and educate patients on nutrition. This review summarised some of the main findings of peer-reviewed articles focusing on pulmonary rehabilitation that were published in the 12 months prior to the 2013 European Respiratory Society Annual Congress in Barcelona. The reviewed findings included...
• short-term and long-term improvements in exercise capacity did not transfer into increased daily physical activity in patients with COPD
• comorbidities are present in about 50-60% of patients with COPD entering pulmonary rehabilitation with five clusters: less comorbidity, cardiovascular, cachectic, metabolic, and psychological
• dyspnoeic, non-hypercapnic patients with COPD and well-established chronic heart failure with reduced left ventricular ejection fraction (<40%) have impaired cerebral oxygenation during progressive exercise compared to their COPD peers without chronic heart failure
• water-based exercise training was significantly more effective than land-based exercise training and the non-exercising control group in improving incremental and endurance shuttle walk distances, and improving aspects of quality of life in patients with COPD with physical comorbidities
• pulmonary rehabilitation during and directly following hospitalisation because of a COPD exacerbation has shown to be very beneficial and cost-effective for patients with COPD
• the use of long-term oxygen therapy and living alone have been identified as independent predictors of poor attendance in patients with stable COPD, whereas current smoking, poor shuttle walk distance and hospitalisation are independent predictors of poor adherence to pulmonary rehabilitation
• most patients with COPD experience a ventilatory limitation during the performance of wholebody endurance exercise training. Training of specific, smaller, lower limb muscle groups will reduce the ventilatory load and, in turn, may increase training load and muscle adaptations The first aim of this meta-analysis was to evaluate exercise training with noninvasive ventilation in terms of physiologic effects after the completion of a pulmonary rehabilitation program. The second aim was to investigate the dose-response relationship between physical improvement and training intensity.
Eight studies provided a proper description of a training schedule in stable COPD patients. A similar effect between NIV and placebo was observed for the outcomes considered despite differences between studies. However, subjects experienced a relevant and statistically significant improvement after rehabilitation for almost all of the outcomes considered. Heart rate (6 beats/min [95% CI 0.94-11.01], P = .02), work load (9.73 W [95% CI 3.78-15.67], P < .001), and oxygen consumption (242.11 mL/min [95% CI 154.93-329.9], P < .001) significantly improved after training. Improvements in heart rate and work load were significantly correlated to training intensity.
Ng L W C, Mackney J, Jenkins S and Hill K (2012) Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis, Chronic Respiratory Disease 9 (1) :
17-26
A systematic review and meta-analysis to examine the effect of exercise training on daily physical activity (PA) in people with chronic obstructive pulmonary disease (COPD).
Study quality for the randomised trials (RTs) and single-group interventional studies was rated using the PEDro scale and Downs and Black Tool, respectively. No randomised controlled trials met the study criteria. The two RTs had a mean PEDro score of 5. The 5 single-group studies had a mean Downs and Black score of 19 ± 3. When combined, a small effect on PA outcomes was demonstrated (overall mean effect = 0.12; p = 0.01). Taken together, the RTs and single-group studies demonstrate that exercise training may confer a significant but small increase in PA.
Beauchamp M K, Janaudis-Ferreira T, Goldstein R S and Brooks D (2011) Optimal duration of pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease -a systematic review, Chronic Respiratory Disease 8 (2) : 129-140
A review to determine the impact of duration of pulmonary rehabilitation on measures of health-related quality of life and exercise tolerance in individuals with chronic obstructive pulmonary disease (COPD).
Three trials reported a difference in health-related quality of life in favour of the longer duration program; two trials reported a benefit in exercise capacity in favour of longer programs. A meta-analysis of results was not possible due to considerable heterogeneity in program duration and outcomes.
Longer duration pulmonary rehabilitation programs appear to have a more favourable effect on healthrelated quality of life in individuals with COPD; results for exercise capacity are less clear. The aim of this review was to determine the factors associated with uptake and completion of pulmonary rehabilitation for people with COPD. Travel and transport were consistently identified as barriers to both uptake and completion. A lack of perceived benefit of pulmonary rehabilitation also influenced both uptake and completion. The only demographic features that consistently predicted non-completion were being a current smoker (pooled odds ratio 0.17, 95% confidence interval 0.10 to 0.32) and depression. The limited data available regarding barriers to uptake indicated that disruption to usual routine, influence of the referring doctor and program timing were important. Conclusion: poor access to transport and lack of perceived benefit affect uptake of pulmonary rehabilitation. Current smokers and patients who are depressed are at increased risk of non-completion. Enhancing attendance in pulmonary rehabilitation will require more attention to transportation, support for those at risk of non-completion and greater involvement of patients in informed decisions about their care. A meta-analysis of randomised controlled trials of respiratory rehabilitation in patients with COPD that assessed functional or maximal exercise capacity, HRQL, or both. Respiratory rehabilitation was defined as exercise training (for at least 4 weeks) with or without education, psychological support, or both. The most commonly used measure for HRQL was the chronic respiratory questionnaire, in which responses were presented on a 7-point scale. The control groups received no rehabilitation. 14 trials were included. Significant improvements were found for all the outcomes. For two important features of HRQL, dyspnoea and mastery, the overall treatment effect was larger than the MCID: 1·0 (95% CI 0·6-1·5) and 0·8 (0·5-1·2), respectively, compared with an MCID of 0·5. For functional exercise capacity (6-min walk test), the overall effect was 55·7 m (27·8-92·8), and for maximum exercise capacity (incremental cycle ergometer test), 8·3 W (2·8-16·5). Functional exercise capacity showed heterogeneity that could not be explained by the sensitivity analyses.
Summary: Respiratory rehabilitation relieves dyspnoea and improves control over COPD. These improvements are clinically important. The value of the improvement in exercise capacity is not clear. Respiratory rehabilitation is an effective part of care in patients with COPD..
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Study Methods Findings
Blackstock F C, Webster K E, McDonald C F and Hill C J (2014) Comparable improvements achieved in chronic obstructive pulmonary disease through pulmonary rehabilitation with and without a structured educational intervention: A randomized controlled trial, Respirology 19 (2) : [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] This trial sought to determine whether the addition of education to exercise training resulted in greater improvements in health outcomes than pulmonary rehabilitation where education has been omitted. A randomized trial with allocation concealment, assessor blinded to group allocation and intentionto-treat analysis was conducted. Two hundred and sixty-seven people with COPD (mean age 72 (9) years, forced expiratory volume in 1?s, 59(23)% predicted) were allocated to receive either 8 weeks of twice weekly group exercise training plus education or exercise training alone. Education was disease specific with a self-management focus. Primary outcome measures included 6-min walk distance and Chronic Respiratory Questionnaire. Secondary outcomes included dyspnoea, health behaviours, generic health-related quality of life, self-efficacy and healthcare usage with measurements taken immediately following completion and at 6 and 12 months.
There were no significant differences that indicated greater improvement in any health outcome with the addition of education. The two intervention groups had similar significant improvements immediately following intervention, and these were maintained comparably in the subsequent 12 months.
Conclusions:
The results of this investigation suggest that disease-specific group education is not an essential component of pulmonary rehabilitation. Pulmonary rehabilitation based on exercise training is an effective option in the management of patients with COPD if multidisciplinary education cannot be offered. (2013) The cost-effectiveness of a structured education pulmonary rehabilitation programme for chronic obstructive pulmonary disease in primary care: the PRINCE cluster randomised trial, BMJ Open 3
To assess the effectiveness and costeffectiveness of a structured education pulmonary rehabilitation programme (SEPRP) for chronic obstructive pulmonary disease (COPD) relative to usual practice in primary care. Participants allocated to the intervention group had statistically significant higher mean change total CRQ scores (adjusted mean difference (MD) 1.11, 95% CI 0.35 to 1.87). Participants allocated to the intervention group also had statistically significant higher mean CRQ Dyspnoea scores after intervention (adjusted MD 0.49, 95% CI 0.20 to 0.78) and CRQ Physical scores (adjusted MD 0.37, 95% CI 0.14 to 0.60).
The intervention was associated with an increase of €944 (95% CIs 489 to 1400) in mean healthcare cost and €261 (95% CIs 226 to 296) in mean patient cost. The intervention was associated with a mean improvement of 1.11 (95% CIs 0.35 to 1.87) in CRQ Total score and 0.002 (95% CIs -0.006 to 0.011) in QALYs gained. These translated into incremental cost-effectiveness ratios of €850 per unit increase in CRQ Total score and €472 per additional QALY gained. The probability of the intervention being cost-effective at respective threshold values of €5000, €15 000, €25 000, €35 000 and €45 000 was 0.980, 0.992, 0.994, 0.994 and 0.994 in the CRQ Total score analysis compared to 0.000, 0.001, 0.001, 0.003 and 0.007 in the QALYs gained analysis.
While analysis suggests that SEPRP was costeffective if society is willing to pay at least €850 per one-point increase in disease-specific CRQ, no evidence exists when effectiveness was measured in QALYs gained. To assess whether the current pulmonary rehabilitation programme could be shortened a randomised controlled trial was conducted in 44 patients with COPD who were allocated to either a seven week or a four week course. They were assessed at baseline and at completion by the Chronic Respiratory Questionnaire (CRQ), the Breathing Problems Questionnaire (BPQ), the incremental shuttle walking test (SWT), and the treadmill endurance test (TET)
Patients who completed the seven week rehabilitation programme had greater improvements in all outcome measures than those undertaking the four week course. These differences reached clinical and statistical significance for the total CRQ score, which was the primary outcome variable (mean difference (95% confidence intervals (CI) of difference) -0.61(-0.15 to -1.08), p<0.05), and the CRQ domains of dyspnoea (-0.80 (95% CI -0.13 to -1.48), p<0.05), emotion (-0.89 (95% CI -0.33 to -1.45), p<0.005), and mastery (-0.84 (95% CI -0.10 to -1.58), p<0.05). There were also trends towards greater improvements in exercise assessments in the seven week group but the differences did not reach statistical significance (SWT: mean difference -16.9 (95% CI 24.8 to -58.6), p=0.41; TET: geometric mean difference -1.21 (95% CI -0.60 to -2.47), p=0.56).
Conclusions: A seven week course of pulmonary rehabilitation provides greater benefits to patients than a four week course in terms of improvements in health status. Intention-to-treat analysis was performed for 192 subjects. Both groups did not differ in demographics and baseline variables except for COPD staging, mean FEV1, FEV1%-Pred, Saint George Respiratory Questionnaire SGRQ activity score and COPD-CSES self-efficacy score. Statistical improvements were seen in exercise capacity, health status and self-efficacy within both groups at 6-month post-intervention. Although more favourable improvements in physiological outcomes and health status were demonstrated in Tai Chi group, only the functional exercise capacity showed statistical improvement between groups at 6 months post-intervention (ß = 12.786 m; 95% CI = 3.794, 21.777; p = 0.006).
Conclusion: The adjuvant effect of incorporating
Tai Chi in pulmonary rehabilitation showed a modest complementary benefit in exercise capacity. This study was performed to determine whether acupuncture is superior to placebo needling in improving DOE in patients with COPD who are receiving standard medication.
Methods: Sixty-eight of 111 patients from the Kansai region of Japan who were diagnosed as having COPD and were receiving standard medication participated in a randomized, parallelgroup, placebo-controlled trial (July 1, 2006 , through March 31, 2009 ) in which the patients, evaluators, and statistician were unaware of the random allocation. Participants were randomly assigned to traditional acupuncture (real acupuncture group, n = 34) or placebo needling (placebo acupuncture group, n = 34). Both groups received real or placebo needling at the same acupoints once a week for 12 weeks. The primary end point was the modified Borg scale score evaluated immediately after the 6-minute walk test. Measurements were obtained at baseline and after 12 weeks of treatment. To evaluate the utility of a 3-week pulmonary rehabilitation (PR) programme in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
Patients admitted with AECOPD, following clinical stabilisation in the respiratory intensive care unit (RICU), were alternately assigned to intervention (n=15); and control groups (n=15), respectively. The intervention group patients were treated with usual care plus PR exercises in the form of 20 minutes each of walking, bicycle ergometry and resistance exercises, thrice-weekly for three weeks. The control group patients were treated with only the usual care. After discharge from hospital the treatment regimens were continued on alternate days on outpatient basis, for a total of three weeks.
Nine sessions of PR exercises produced statistically significant improvement in general well-being, forced expiratory volume in the first second (FEV1), 6MWT parameters, exercise capacity, peak oxygen uptake and volume of oxygen consumption (VO2)/Watts slope on CPET in patients with AECOPD.
Conclusion: Short duration PR programmes appear to be helpful in the management of AECOPD.
Ramos E M C, de Toledo-Arruda A C, Fosco L C, Bonfim R, Bertolini G N, Guarnier F A, Cecchini R, Pastre C M, Langer D, Gosselink R and Ramos D After eight weeks, the mean distance covered during six minutes increased by 73 metres (±69) in the elastic tubing group and by 42 metres (±59) in the conventional group (p < 0.05). The muscle strength and quality of life improved in both groups (P < 0.05), with no significant differences between the groups. There was a trend toward an improved fat-free mass in both groups (P = 0.05). After the first and last sessions, there was an increase in interleukin 1ß (IL-1ß) and interleukin 10 (IL-10) in both groups, while tumour necrosis factor alpha (TNF-a) was stimulated only in the conventional training group. This randomised controlled trial aimed to determine the effectiveness of water-based exercise training in improving exercise capacity and quality of life compared to land-based exercise training and control (no exercise) in people with COPD and physical co-morbidities. Participants referred to pulmonary rehabilitation were randomly allocated to a water-based exercise, land-based exercise or the control group. The two exercise groups trained for 8 weeks, completing three sessions per week. Forty five out of 53 participants (mean±sd age 72±9 years; completed the study.
Conclusion
Compared to controls, water-based exercise training significantly increased 6-min walking distance, incremental and endurance shuttle walk distances, and improved Chronic Respiratory Disease Questionnaire (CRDQ) dyspnoea and fatigue. Compared to land-based exercise training, water-based exercise training significantly increased incremental shuttle walk distance (mean difference 39 m, 95% CI 5-72 m), endurance shuttle walk distance (mean difference 228 m, 95% CI 19-438 m) and improved CRDQ fatigue.
Water-based exercise training was significantly more effective than land-based exercise training and control in increasing peak and endurance exercise capacity and improving aspects of quality of life in people with COPD and physical comorbidities.
Revitt O, Sewell L, Morgan M D L, Steiner M and Singh S (2013) Short outpatient pulmonary rehabilitation programme reduces readmission following a hospitalization for an exacerbation of chronic obstructive pulmonary disease, Respirology 18 (7) : 1063-1068
This study aimed to explore the effectiveness of a short outpatient PR programme and the impact upon readmission rates. One hundred sixty (87 males) patients, mean (SD) age 70.35 (8.59) years, forced expiratory volume in 1 s 0.99 (0.44) litres were assessed for a 7week PR programme following a hospital admission for an acute exacerbation of COPD.
Patients were assessed and commenced PR within 4 weeks of discharge from hospital. Outcome measures included: Incremental Shuttle Walking Test (ISWT), Endurance Shuttle Walk Test (ESWT), Chronic Respiratory Questionnaire Self-Reported (CRQ-SR). Patients were assessed at baseline and at 7 weeks (after the 4-week supervised and 3-week unsupervised components). Readmission data were collected retrospectively for the 12 months pre and post admission (n=155).
Statistically significant improvements were found in the ISWT, ESWT and CRQ-SR at discharge (P<0.05). The number of admission was significantly less in the 12-month post-pulmonary rehabilitation compared to the previous 12 months.
Conclusions: A short course of PR showed improvements in exercise capacity and health status in patients who have had an acute exacerbation of COPD. The number of readmissions was also significantly lower in the year following PR. Immediately after the 4-week DBTP, the TG showed a greater abdominal motion during natural breathing quantified by a reduction in the RC/ABD ratio when compared with the CG (F=8.66; P<.001). Abdominal motion during voluntary diaphragmatic breathing after the intervention was also greater in the TG than in the CG (F=4.11; P<.05). The TG showed greater diaphragmatic mobility after the 4-week DBTP than did the CG (F=15.08; P<.001). An improvement in the 6minute walk test and in health-related quality of life was also observed in the TG.
Conclusions:
DBTP for patients with chronic obstructive pulmonary disease induced increased diaphragm participation during natural breathing, resulting in an improvement in functional capacity. Results suggest that the intervention may increase both QoL (mean EQ-5D change 0.12 (95% confidence interval [CI] = -0.02 to 0.26) higher, intervention versus control) and exercise levels, but not SGRQ score. Economic analyses suggested that with thresholds of £20 000 per quality-adjusted life-year gained, the intervention is likely to be cost-effective.
Conclusion: This intervention has good potential to meet the UK National Institute for Health and Clinical Excellence criteria for cost effectiveness. However, to make a substantial impact on COPD self-management, it will also be necessary to explore other ways to enable patients to access self-management education. Although the addition of NIPPV did not significantly improve the Chronic Respiratory Questionnaire compared to rehabilitation alone (mean difference in change between groups -1.3 points (95% CI: -9.7 to 7.4)), the addition of NIPPV did improve HRQoL assessed with the Maugeri Respiratory Failure questionnaire (-13.4% (-22.7 to -4.2; p = 0.005)), mood state (Hospital Anxiety and Depression scale -4.0 points (-7.8 to 0.0; p = 0.05)), dyspnoea (Medical Research Council -0.4 points (-0.8 to -0.0; p = 0.05)), daytime arterial blood gases (PaCO2 -0.4 kPa (-0.8 to -0.2; p = 0.01); PaO2 0.8 kPa (0.0 to 1.5; p = 0.03)), 6minute walking distance (77.3 m (46.4 to 108.0; p < 0.001)), Groningen Activity and Restriction scale (-3.8 points (-7.4 to -0.4; p = 0.03)), and forced expiratory volume in 1 second (115 ml (19 to 211; p = 0.019)). Exacerbation frequency was not changed.
Conclusions: The addition of NIPPV to pulmonary rehabilitation for 2 years in severe COPD patients with chronic hypercapnic respiratory failure improves HRQoL, mood, dyspnoea, gas exchange, exercise tolerance and lung function decline. The benefits increase further with time. Early pulmonary rehabilitation, compared with usual care, led to significant improvements in median incremental shuttle walk distance (60 metres, 95% confidence interval 26.6 metres to 93.4 metres, P = 0.0002), mean SGRQ total score (-12.7, -5 .0 to -20.3, P = 0.002), all four domains of the CRQ (dyspnoea 5.5, 2.0 to 9.0, P = 0.003; fatigue 5.3, 1.9 to 8.8, P = 0.004; emotion 8.7, 2.4 to 15.0, P = 0.008; and mastery 7.5, 4.2 to 10.7, P < 0.001) and the mental component score of the SF-36 (20.1, 3.3 to 36.8, P = 0.02). Improvements in the physical component score of the SF-36 did not reach significance (10.6, -0.3 to 21.6, P = 0.057).
Conclusion: Early pulmonary rehabilitation after admission to hospital for acute exacerbations of COPD is safe and leads to statistically and clinically significant improvements in exercise capacity and health status at three months. To investigated the short-and long-term effects of a 6-month outpatient rehabilitation program in patients with severe COPD, one hundred patients were randomly assigned to receive either an exercise training program that included cycling, walking, and strength training (n = 50) or usual medical care (n = 50). Thirty-four patients in the training group were evaluated after 6 months (end of training), and 26 were evaluated after 18 months of follow-up. In the control group, 28 patients were evaluated at 6 months and 23 after 18 months. Measures: pulmonary function, 6-minute walking distance, maximal exercise capacity, peripheral and respiratory muscle strength, and quality of life (on a 20 to 140-point scale), and estimated costeffectiveness of the program.
At 6 months, the training group showed improvement in 6-minute walking distance [mean difference (training -control) of 52 m; 95% confidence interval (CI), 15 to 89 m], maximal work load (12 W; 95% CI, 6 to 19 W), maximal oxygen uptake (0.26 liters/min; 95% CI, 0.07 to 0.45 liters/min), quadriceps force (18 Nm; 95% CI, 7 to 29 Nm), inspiratory muscle force (11 cm H2O; 95% CI, 3 to 20 cm H2O), and quality of life (14 points; 95% CI, 6 to 21 points; all P <0.05). At 18 months all these differences persisted (P <0.05), except for inspiratory muscle strength. For 6-minute walking distance and quality of life, the differences between the training group and controls at 18 months exceeded the minimal clinically-important difference.
Conclusion: Among patients who completed the 6month program, outpatient training resulted in significant and clinically relevant changes in 6minute walking distance, maximal exercise performance, peripheral and respiratory muscle strength, and quality of life. Most of these effects persisted 18 months after starting the program. Two hundred patients with severe chronic obstructive pulmonary disease (COPD) were recruited for a prospective randomized trial of pulmonary rehabilitation versus bilateral lung volume reduction surgery (LVRS) with stapling resection of 20 to 40% of each lung. Pulmonary function tests, gas exchange, 6-min walk distance, and symptom-limited maximal exercise testing were done in all patients at baseline and after 8 wk of rehabilitation. Patients were then randomized to either 3 additional months of rehabilitation or LVRS. Thirty-seven patients met study criteria and were enrolled into the trial. Eighteen patients were in the medical arm; 15 of 18 patients completed 3 mo of additional pulmonary rehabilitation. Thirty-two patients underwent LVRS (19 in the surgical arm, 13 cross-over from the medical arm).
After 8 wk of pulmonary rehabilitation, pulmonary function tests remained unchanged compared with baseline data. However, there was a trend toward a higher 6-min walk distance (285 ± 96 versus 269 ± 91 m, p = 0.14) and total exercise time on maximal exercise test was significantly longer compared with baseline values (7.4 ± 2.1 versus 5.8 ± 1.7 min, p < 0.001).
In 15 patients who completed 3 mo of additional rehabilitation, there was a trend to a higher maximal oxygen consumption. The Sickness Impact Profile (SIP), a generalized measure of quality of life (QOL), was significantly improved after 8 wk of rehabilitation and was maintained after 3 mo of additional rehabilitation. A further improvement in QOL was observed 3 mo after LVRS compared with the initial improvement gained after 8 wk of rehabilitation. Conclusion: Bilateral LVRS, in addition to pulmonary rehabilitation, improves static lung function, gas exchange, and QOL compared with pulmonary rehabilitation alone.
Wedzicha J A, Bestall J C, Garrod R, Garnham R, Paul E A and Jones P W (1998) Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale, European Respiratory Journal 12 (2) : [363] [364] [365] [366] [367] [368] [369] This study tested the hypothesis that severity of respiratory disability may affect the outcome of pulmonary rehabilitation. In this randomized, controlled study, 126 patients with chronic obstructive pulmonary disease (COPD) were stratified for dyspnoea using the Medical Research Council (MRC) dyspnoea score into MRC3/4 (Moderate) (n=66) and MRC 5 (Severe) dyspnoeic (n=60) groups. The patients were randomly assigned to an eight week programme of either exercise plus education (Exercise group) or education (Control group). Education and exercise programmes for the moderately dyspnoeic patients were carried out in a hospital outpatient setting. Severely dyspnoeic patients were all treated at home. Those in the Exercise group received an individualized training programme.
There was a significant improvement in shuttle walking distance in the moderate dyspnoeic group, who received exercise training; baseline (mean+/-SEM) 191+/-22 m, post-rehabilitation 279+/-22 m (p<0.001). There was no improvement in exercise performance in the severely dyspnoeic patients receiving exercise. Neither group of control patients improved. Health status, assessed by the Total Chronic Respiratory Disease Questionnaire score, increased in the moderately dyspnoeic patients receiving exercise from 80+/-18 to 95+/-17 (p<0.0001) after rehabilitation. Much smaller changes were seen in the other three groups. Improvement in exercise performance and health status in patients with chronic obstructive pulmonary disease after an exercise programme depends on the initial degree of dyspnoea.
